Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,406
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 28. Ubil E, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514(7524):585–590. doi: 10.1038/nature13839. · DOI · Paper page
Cited by
Items 201–300 of 638
Fernández‐Mayola, M., & Thackeray, J. T. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01869-8 · Cited by 34
Quijada, P. J., Misra, A., Velasquez, L. S., Burke, R. M., Lighthouse, J. K., Mickelsen, D. M., Dirkx, R. A., & Small, E. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.015 · Cited by 33
Atomic Force Microscopy (AFM) Applications in Arrhythmogenic Cardiomyopathy
Peña, B., Adbel-Hafiz, M., Cavasin, M. A., Mestroni, L., & Sbaizero, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073700 · Cited by 35
“Fixed tissues have also been analyzed by AFM [66]; Iwashita et al.”
MethodThe role of interleukin-33 in organ fibrosis
Carmine, S. D., Scott, M. M., McLean, M. H., & McSorley, H. J. (2022) · Discovery Immunology · doi:10.1093/discim/kyac006 · Cited by 36
“As cardiomyocytes are mostly unable to regenerate following injury, tissue remodelling occurs, and scar tissue is formed to compensate for the necrosed cells and prevent rupture of the ventricular wall [115, 116].”
BackgroundWang, H., Yang, J., Cai, Y., & Zhao, Y. (2024) · Protein & Cell · doi:10.1093/procel/pwae013 · Cited by 31
“For isolation of MICFs, hearts were excised from C57BL/6 mice with MI surgery on Day 6 to ensure the isolated cardiac fibroblasts stayed in the cell identity of myofibro-blasts (Fu et al., 2018).”
Yoshida, S., Yoshida, T., Inukai, K., Kato, K., Yura, Y., Hattori, T., Enomoto, A., Ohashi, K., Okumura, T., Ouchi, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52068-0 · Cited by 37
Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming
Bektik, E., & Fu, J. (2019) · Cells · doi:10.3390/cells8070679 · Cited by 31
“However, the majority of activated fibroblasts have been differentiated into αSMA+ myofibroblasts and further become αSMA− matrifibrocytes in a chronic scar [42].”
BackgroundHan, X., Zhao, Z., Yan, S., Lei, W., Wu, H., Lu, X., Chen, Y., Li, J., Wang, Y., Yu, M., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15955 · Cited by 30
Li, Y., Li, C., Liu, Q., Wang, L., Bao, A. X., Jung, J. P., Dodlapati, S., Sun, J., Gao, P., Zhang, X., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.08.003 · Cited by 30
“Using this method, we previously identified that the proliferation of cardiac fibroblasts after MI peaked at day 3 after MI and was largely diminished beyond day 7 post-MI [4].”
BackgroundMethodInfluentialSelf-citationUmbarkar, P., Ramirez, S. Y. R., Cora, A. T., Tousif, S., & Lal, H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166724 · Cited by 33
Stauffer, W. T., Blackwood, E. A., Azizi, K., Kaufman, R. J., & Glembotski, C. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041373 · Cited by 30
“These fibers can be stained by fluorescent antibodies to αSMA and imaged as a final sign of full myofibroblast activation [24,33].”
BackgroundChamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction
Luo, X., Yin, J., Dwyer, D., Yamawaki, T., Zhou, H., Ge, H., Han, C.-Y. E., Shkumatov, A. A., Snyder, K., Ason, B. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91214-2 · Cited by 34
Interleukin-1β polarization in M1 macrophage mediates myocardial fibrosis in diabetes
Guo, W., Yang, C., Zou, J., Yu, T., Li, M., He, R., Chen, K., Hell, R. C. R., Gross, E. R., Zou, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111858 · Cited by 33
Growth factor therapy for cardiac repair: an overview of recent advances and future directions
White, S., & Chong, J. J. H. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00734-0 · Cited by 31
Zhou, Y., Ng, D. Y., Richards, M., & Wang, P. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.041 · Cited by 29
“MyocFB was indicated by percent of a-SMA cells.(51)”
BackgroundLi, J., Li, Z., Ouyang, X.-P., & He, P. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701279 · Cited by 36
“Neointimal hyperplasia mainly occurs in the middle or late stages of atherosclerosis, especially after PCI (20, 36, 115, 116).”
BackgroundRole of Cardiac Fibroblasts in Cardiac Injury and Repair
Han, M., & Zhou, B. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01647-y · Cited by 32
Du, L., Sun, X., Gong, H., Wang, T. Z., Jiang, L., Huang, C., Xu, X., Li, Z., Xu, H., Ma, L., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03256-0 · Cited by 34
“There are various reports on the changes of fibroblast subsets [8], e.”
BackgroundHume, R. D., Deshmukh, T., Doan, T., Shim, W. J., Kanagalingam, S., Tallapragada, V. J., Rashid, F. N., Marcuello, M., Blessing, D., Selvakumar, D., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.11.006 · Cited by 31
Chen, H., Hu, K., Tang, Q., Wang, J., Gu, Q., Chen, J., Hu, J., Peng, N., Guo, M., Jiang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56703-2 · Cited by 28
“F-MFC represents matri fi brocytes, which were characterized by high expression of Comp and mainly distributed in the myocardial scars and play a functional role in maintaining the integrity of the mature scar 11 – 13 .”
Constanty, F., Wu, B., Wei, K.-H., Lin, I.-T., Dallmann, J., Günther, S., Lautenschlaeger, T., Priya, R., Lai, S.-L., Stainier, D. Y. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59169-4 · Cited by 43
“…mammalian heart, while cardiac fi broblasts are essential for the initial wound healing response and for preventing ventricular rupture 83 , activation of fi broblasts, excessive ECM deposition, and the remaining presence of fi broblasts within the scar lead to a mature and permanent scar 84 – 86 .”
Cardiac fibroblasts in myocardial injury and heart failure
Linthout, S. V., Matz, I., González, A., & Davis, J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf902 · Cited by 48
Wells, A. R., & Leung, K. P. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.177 · Cited by 30
Heart regeneration: beyond new muscle and vessels
Sayers, J. R., & Riley, P. R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa320 · Cited by 30
Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin
Burke, R. M., Dirkx, R. A., Quijada, P. J., Lighthouse, J. K., Mohan, A. M., O’Brien, M., Wojciechowski, W., Woeller, C. F., Phipps, R. P., Alexis, J. D., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317791 · Cited by 28
Bao, H., Wang, X., Zhou, H., Zhou, W., Liao, F., Wei, F., Yang, S., Luo, Z., & Li, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115996 · Cited by 33
Cui, Y., Wang, Y., Wang, S., Du, B., Li, X., & Li, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186033 · Cited by 29
“Once activated, fibroblasts in the heart and vessel differentiate into profibrotic phenotypes, defined as myofibroblasts, secreting more extracellular matrices, and participating in the subsequent formation of a collagen scar [16,17].”
BackgroundSGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation
Schmidt, K., Schmidt, A., Groß, S., Just, A., Pfanne, A., Fuchs, M., Jordan, M., Mohr, E., Pich, A., Fiedler, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65410-9 · Cited by 33
“Conversely, expression analyses of several genes representing different stages of fibrosis 53 could not confirm an overall reduction of fibroblasts activation.”
BackgroundTranscription Factor 21 Regulates Cardiac Myofibroblast Formation and Fibrosis
Johansen, A. K. Z., Kasam, R. K., Vagnozzi, R. J., Lin, S. J., Gomez‐Arroyo, J. G., Shittu, A., Bowers, S., Kuwabara, Y., Grimes, K. M., Warrick, K. A., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.325527 · Cited by 31
Self-citationTargeting p16INK4a Promotes Lipofibroblasts and Alveolar Regeneration after Early-Life Injury
Zysman, M., Baptista, B. R., Essari, L.-A., Taghizadeh, S., de Ménonville, C. T., Giffard, C., Issa, A., Franco‐Montoya, M., Breau, M., Souktani, R., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1573oc · Cited by 29
Liu, Z., Klose, K., Neuber, S., Jiang, M., Gossen, M., & Stamm, C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02605-4 · Cited by 30
Misra, A., Baker, C. D., Pritchett, E. M., Villar, K. N. B., Ashton, J. M., & Small, E. M. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9010001 · Cited by 28
Miller, J. M., Meki, M., Elnakib, A. A., Ou, Q., Abouleisa, R., Tang, X., Salama, A. B. M., Gebreil, A., Lin, C., Abdeltawab, H., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03919-3 · Cited by 33
Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis
Hara, A., & Tallquist, M. D. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01877-8 · Cited by 32
Fibroblast Activation Protein Targeting Probe with Gly–Pro Sequence for PET of Glioblastoma
Lai, C., Cao, R., Li, R., He, C., Wang, X., Shi, H., Qu, C., Qian, K., Song, S., Chen, W., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00248 · Cited by 26
Understanding Fibroblast Heterogeneity in Form and Function
Parker, J. B. L., Valencia, C., Akras, D., DiIorio, S. E., Griffin, M., Longaker, M. T., & Wan, D. C. (2023) · Biomedicines · doi:10.3390/biomedicines11082264 · Cited by 36
Hydrogel-based cardiac patches for myocardial infarction therapy: Recent advances and challenges
Liu, Z., Zheng, Z., Xie, J., Wei, H., & Yu, C. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101331 · Cited by 44
Chimenti, I., Pagano, F., Cozzolino, C., Icolaro, F., Floris, E., & Picchio, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125882 · Cited by 29
Sadahiro, T. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.06.004 · Cited by 27
Stiffness of thermoresponsive gelatin-based dynamic hydrogels affects fibroblast activation
Perera, M. M., Fischesser, D. M., Molkentin, J. D., & Ayres, N. (2019) · Polymer Chemistry · doi:10.1039/c9py01424a · Cited by 29
Self-citationRepurposing Nintedanib for Pathological Cardiac Remodeling and Dysfunction
Umbarkar, P., Singh, A. P., Tousif, S., Zhang, Q., Sethu, P., & Lal, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2021.105605 · Cited by 29
Modulation of Cardiac Fibrosis in and Beyond Cells
Dong, F., & Kassiri, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.750626 · Cited by 31
“In response to injury or inflammation, cardiac fibroblasts are activated and differentiated into myofibroblasts which increase synthesis and secretion of ECM proteins leading to fibrosis (Khalil et al., 2017; Fu et al., 2018; Aujla and Kassiri, 2021).”
BackgroundCardiomyocyte-fibroblast interaction regulates ferroptosis and fibrosis after myocardial injury
Mohr, M., Li, S., Trouten, A. M., Stairley, R. A., Roddy, P. L., Liu, C., Zhang, M., Sucov, H. M., & Tao, G. (2024) · iScience · doi:10.1016/j.isci.2024.109219 · Cited by 28
Sall4 and Myocd Empower Direct Cardiac Reprogramming From Adult Cardiac Fibroblasts After Injury
Zhao, H., Zhang, Y., Xu, X., Sun, Q., Yang, C., Wang, H., Yang, J., Yang, Y., Yang, X., Liu, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.608367 · Cited by 26
“, 2017), we found more than 2,000 genes were differently expressed in MICFs, in consistent with the previous report (Fu et al., 2018).”
BackgroundResultSaljic, A., Grandi, E., & Dobrev, D. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161070 · Cited by 26
Chowkwale, M., Lindsey, M. L., & Saucerman, J. J. (2022) · The Journal of Physiology · doi:10.1113/jp283346 · Cited by 25
“…MI was conducted to identify the main components (Anzai et al., 2017; Bujak & Frangogiannis, 2007; DeLeon-Pennell et al., 2017; Forte et al., 2020; Fu et al., 2018; Heidt et al., 2014; Leuschner et al., 2012; Ma et al., 2018; Martin & Blaxall, 2012; Prabhu & Frangogiannis, 2016; Sager et al.,…”
BackgroundMethodThe Formation of Coronary Vessels in Cardiac Development and Disease
He, L., Lui, K. O., & Zhou, B. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037168 · Cited by 27
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy
Wang, B. Z., Morsink, M. A. J., Kim, S. W., Luo, L. J., Zhang, X., Soni, R. K., Lock, R. I., Rao, J., Kim, Y., Zhang, A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci181630 · Cited by 23
Wermuth, P. J., Mendoza, F. A., & Jiménez, S. A. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0161-1 · Cited by 26
Angiotensin-II-Evoked Ca2+ Entry in Murine Cardiac Fibroblasts Does Not Depend on TRPC Channels
Londoño, J. E. C., Marx, A., Kraft, A. E., Schürger, A., Richter, C., Dietrich, A., Lipp, P., Birnbaumer, L., & Freichel, M. (2020) · Cells · doi:10.3390/cells9020322 · Cited by 23
“Recently, matrifibrocytes were described, which develop from myofibroblasts and persist in the scar after myocardial infarction giving structural support [12].”
BackgroundPerez‐Mies, B., Caniego-Casas, T., Bardi, T., Carretero‐Barrio, I., Benito, A., García‐Cosío, M., González-García, I., Pizarro, D., Cancio-Suárez, M. R., Cristóbal, E., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.976759 · Cited by 23
“Our study also demonstrated that areas of mature fibrosis were devoid of cells expressing CTHRC1, SPARC or α-actin, suggesting that loss a “pathological” or “activated” fibroblast phenotype was associated with fibrosis maturation, as previously reported during heart infarct scar maturation (25).”
CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy
Schary, Y., Rotem, I., Caller, T., Lewis, N., Shaihov–Teper, O., Brzezinski, R. Y., Lendengolts, D., Raanani, E., Sternik, L., Naftali‐Shani, N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-31286-4 · Cited by 28
Potential molecular mechanism underlying cardiac fibrosis in diabetes mellitus: a narrative review
Ridwan, M. Q., Dimiati, H., Syukri, M., & Lesmana, R. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00376-z · Cited by 32
“Under normal conditions, fibroblasts are in a resting or inactive state; however, they can be activated by the remaining healthy cardiac tissue whenever cardiac cell injury occurs [47].”
BackgroundMicroRNAs regulating signaling pathways in cardiac fibrosis: potential role of the exercise training
Caria, A. C. I., Rodrigues, L. F., Joaquim, V. H. A., Sousa, R. A. L. D., Fernandes, T. M., & de Oliveira, E. M. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00410.2023 · Cited by 25
βIV-Spectrin/STAT3 complex regulates fibroblast phenotype, fibrosis, and cardiac function
Patel, N., Nassal, D. M., Greer-Short, A., Unudurthi, S. D., Scandling, B. W., Gratz, D. H., Xu, X., Kalyanasundaram, A., Fedorov, V. V., Accornero, F., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131046 · Cited by 24
“activity of MerCreCre under Postn promoter (6, 38).”
BackgroundHuang, Y., Wang, Y., Wang, X., Lin, L., Wang, P., Sun, J., & Jiang, L. (2020) · Medical Science Monitor · doi:10.12659/msm.920736 · Cited by 33
“The mechanism of hypertrophic scar formation is associated with abnormal cell proliferation, the transformation of fibroblasts in response to damage, stimulation of cytokines, including TGF-b, and upregulation of genes such as a-SMA, which are involved in the extracellular matrix (ECM), collagen, and fibronectin produ…”
BackgroundFibro-fatty remodelling in arrhythmogenic cardiomyopathy
Kohela, A., & van Rooij, E. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00929-4 · Cited by 25
“This was observed in models of pressure overload [1, 62] and MI [29, 41, 67, 84].”
MethodHuman engineered heart tissue transplantation in a guinea pig chronic injury model
von Bibra, C., Shibamiya, A., Geertz, B., Querdel, E., Koehne, M., Stüdemann, T., Starbatty, J., Schmidt, F. N., Hansen, A., Hiebl, B., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.01.007 · Cited by 25
Cardiac fibroblasts in heart failure and regeneration
Harrington, A., & Moore‐Morris, T. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1388378 · Cited by 29
Fibroblast Diversity and Epigenetic Regulation in Cardiac Fibrosis
Aguado‐Alvaro, L. P., Garitano, N., & Pelacho, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116004 · Cited by 27
“The presence of this fibroblast subpopulation was confirmed by Faberhi et al. in both healthy and infarcted hearts obtained from a Pdgfr α -GFP mouse model [10].”
BackgroundInfluentialThe innate immune regulator MyD88 dampens fibrosis during zebrafish heart regeneration
Goumenaki, P., Günther, S., Kikhi, K., Looso, M., Marín‐Juez, R., & Stainier, D. Y. R. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00538-5 · Cited by 26
“2a,b) could reflect an increase in these endocardium-derived cells. αSMA + myofibroblasts are the key contributors to ECM fibrotic remodeling and scar formation in the injured heart 56,58,60 .”
BackgroundCold and hot fibrosis define clinically distinct cardiac pathologies
Miyara, S., Adler, M., Umansky, K. B., Häußler, D., Bassat, E., Divinsky, Y., Elkahal, J., Kain, D., Lendengolts, D., Flores, R. O. R., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101198 · Cited by 39
Asli, N. S., Xaymardan, M., Patrick, R., Farbehi, N., Cornwell, J. A., Forte, E., Waardenberg, A. J., Janbandhu, V. C., Kesteven, S. H., Chandrakanthan, V., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/225979 · Cited by 27
Li, C., Sun, J., Liu, Q., Dodlapati, S., Ming, H., Wang, L., Li, Y., Li, R., Jiang, Z., Francis, J., et al. (2021) · Epigenetics · doi:10.1080/15592294.2021.1982158 · Cited by 28
“To study the gene expression profiles of cardiac fibroblasts in different differentiation states, we employed the same cardiac fibroblast lineagetracing mouse line (Tcf21; R26) that we used in our previous publication (Figure 1 (a)) [1].”
BackgroundMethodResultInfluentialSelf-citationWu, W. T., Jia, S., Chen, W.-L., Liu, X., & Zhang, S. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.02.108 · Cited by 21
Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts
Brand, C. S., Lighthouse, J. K., & Trembley, M. A. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.023 · Cited by 24
“Indeed, a recent study defined the matrifibrocyte, a specialized myofibroblast that has lost the ability to proliferate but persists after MI resolution to act as a scaffold [133].”
BackgroundCadherin-11 and cardiac fibrosis: A common target for a common pathology
Riley, L. A., & Merryman, W. D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109876 · Cited by 21
“Recent lineage tracing studies have shown that these cells are matrifibrocytes, differentiated myofibroblast-lineage cells that express bone-cartilage markers, lose their proliferative ability, and no longer express α-SMA [23].”
BackgroundPupkaitė, J., Sedláková, V., Çimenci, Ç. E., Bak, M., McLaughlin, S., Ruel, M., Alarcon, E. I., & Suuronen, E. J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00418 · Cited by 20
Patel, N., Nassal, D. M., Gratz, D. H., & Hund, T. J. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1849145 · Cited by 20
Alvandi, Z., Nagata, Y., Passos, L. S. A., Gheinani, A. H., Guerrero, J. L., Wylie‐Sears, J., Romero, D. C., Morris, B. A., Sullivan, S. M., Yaghoubian, K. M., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023695 · Cited by 21
The heart of cardiac reprogramming: The cardiac fibroblasts
Ricketts, S. N., & Li, Q. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.08.004 · Cited by 25
Salvatori, F., D’Aversa, E., Serino, M. L., Singh, A. V., Secchiero, P., Zauli, G., Tisato, V., & Gemmati, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713268 · Cited by 23
Nanoparticles for Postinfarct Ventricular Remodeling
Dong, C., Ma, A., & Shang, L. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0264 · Cited by 22
Slicing and Culturing Pig Hearts under Physiological Conditions
Ou, Q., Abouleisa, R., Tang, X., Juhardeen, H. R., Meki, M. H., Miller, J. M., Giridharan, G. A., El-Baz, A. S., Bolli, R., & Mohamed, T. (2020) · Journal of Visualized Experiments · doi:10.3791/60913 · Cited by 20
Recapturing embryonic potential in the adult epicardium: Prospects for cardiac repair
Redpath, A. N., & Smart, N. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0352 · Cited by 18
“However, with revised interpretation and more cautious use of lineage tracing models, both in the neonate and adult, an epicardial origin appears unlikely, with the majority of de novo CFbs, CECs, vSMCs, and rare CMs post-MI seemingly arising from their respective preexisting resident populations.(6,8,9,11,55-57) Cave…”
BackgroundWu, A., Zhang, L., Chen, J., Li, H., Yang, P., Chen, M., & Liu, Q. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04111-7 · Cited by 21
Harnessing Mechanosensation in Next Generation Cardiovascular Tissue Engineering
Garoffolo, G., Ferrari, S., Rizzi, S., Barbuto, M., Bernava, G., & Pesce, M. (2020) · Biomolecules · doi:10.3390/biom10101419 · Cited by 20
RAS inhibition in resident fibroblast biology
Garvin, A. M., Khokhar, B. S., Czubryt, M. P., & Hale, T. M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109903 · Cited by 21
Desantis, V., Potenza, M. A., Sgarra, L., Nacci, C., Scaringella, A., Cicco, S., Solimando, A. G., Vacca, A., & Montagnani, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065307 · Cited by 20
“electrotonic coupling between myofibroblasts and cardiomyocytes has been suggested to cause cardiomyocyte depolarization and promote triggering activity [30,31].”
BackgroundChu, L., Xie, D., & Xu, D. (2023) · Biomolecules · doi:10.3390/biom13091382 · Cited by 20
“During this process, they differentiate into myofibroblasts, secrete a substantial ECM, and express α-smooth muscle actin (α-SMA) [19].”
BackgroundFibroblast Reprogramming in Cardiac Repair
Wang, Q., Spurlock, B., Liu, J., & Li, Q. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.06.012 · Cited by 21
Nelson, A. R., Christiansen, S. L. M., Naegle, K. M., & Saucerman, J. J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303513121 · Cited by 23
“Recent studies of fibroblast phenotype have shown that fibroblasts exhibit high phenotypic heterogeneity across many facets in response to injury and that phenotypic changes are also sensitive to drug perturbations (8–11).”
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular Therapies
Hume, R. D., & Chong, J. J. H. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.09.006 · Cited by 20
Mechano-chemo signaling interactions modulate matrix production by cardiac fibroblasts
Rogers, J. D., Holmes, J. W., Saucerman, J. J., & Richardson, W. J. (2020) · Matrix Biology Plus · doi:10.1016/j.mbplus.2020.100055 · Cited by 19
In vivo reprogramming as a new approach to cardiac regenerative therapy
Sadahiro, T., & Ieda, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.019 · Cited by 21
Ramos-Regalado, L., Alcover, S., Badimón, L., & Vilahur, G. (2024) · Cells · doi:10.3390/cells13131125 · Cited by 22
“Through the proliferative phase, reparative fi broblasts and di ff erentiated myo fi broblasts synthesize extracellular matrix proteins (to prevent ventricle rupture) and are converted into specialized cells to preserve the scar [82].”
BackgroundActivation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury
Kou, S., Lu, Z., Deng, D., Ye, M., Yu, S., Qin, L., Feng, T., Jiang, Z., Meng, J., Lin, C., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.070738 · Cited by 19
“42 Reduced DNMT1 expression after MI may result in decreased DNA methylation at the ICR of the maternal Pw1 allele in fibroblasts during the proliferative stage, leading to bial-lelic activation of Pw1 in fibroblasts in the injured regions of the MI hearts.”
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
You, E., Patel, B. K., Rojas, A. S., Sun, S., Danaher, P. J., Ho, N. I., Phillips, I. E., Raabe, M. J., Song, Y., Xu, K. H., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1317 · Cited by 21
Wang, J., Bennett, D. S. Y., Echard, E. J., Chen, B., Ciampa, G., Zhao, W., Shi, Q., Yoon, J., Weiss, R. M., Grueter, C. E., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.073937 · Cited by 21
Understanding the Adult Mammalian Heart at Single-Cell RNA-Seq Resolution
Marín‐Sedeño, E., de Morentin, X. M., Pérez-Pomares, J. M., Gómez-Cabrero, D., & Ruiz‐Villalba, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645276 · Cited by 19
“Between 3 and 7 dpi, several fibroblast clusters with proliferation abilities and significant expression of Acta2, appear near the infarct zone (Fu et al., 2018; Farbehi et al., 2019; Forte et al., 2020).”
BackgroundQin, X., Cai, P., Liu, C., Chen, K., Jiang, X., Chen, W., Li, J., Jiao, X., Guo, E., Yu, Y., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.04.020 · Cited by 20
Umbarkar, P., Ejantkar, S., Ramirez, S. Y. R., Cora, A. T., Zhang, Q., Tousif, S., & Lal, H. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01005-1 · Cited by 21
“In the injured myocardium, fibroblasts (FBs) undergo phenotypic changes and play critical roles in wound healing and remodeling [14, 20, 35, 46, 48].”
Fuchs, M., Kreutzer, F. P., Kapsner, L. A., Mitzka, S., Just, A., Perbellini, F., Terracciano, C. M., Xiao, K., Geffers, R., Bogdan, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134727 · Cited by 22
“After initial stabilization, myofibroblasts trigger remodeling and secrete additional ECM to build a long-term scar [19,20].”
BackgroundLandry, N. M., & Dixon, I. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109802 · Cited by 22
Organ fibrosis: beyond collagen I expression. Fibroblast phenotype and basement membrane proteins
Biggs, R. M., & Bradshaw, A. D. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00077.2025 · Cited by 17
Lanzer, J. D., Flores, R. O. R., Liñares-Blanco, J., Steier, M., Rangrez, A. Y., Frey, N., & Sáez-Rodríguez, J. (2025) · Nature Communications · doi:10.1038/s41467-025-62219-6 · Cited by 24
“Fib1( POSTN ⁺ and THBS4 ⁺ ), characterized by the expression of matri fi brocyte markers 43 , was enriched for TGF β signaling and core matrisome-related genes.”
Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice
Gladka, M. M., Johansen, A. K. Z., van Kampen, S. J., Peters, M. M. C., Molenaar, B., Versteeg, D., Kooijman, L., Zentilin, L., Giacca, M., & van Rooij, E. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac155 · Cited by 20
“In response to injury, several cardiac cell types, especially fibroblasts, undergo dynamic changes, including activation of the cell cycle to mount the regenerative response.(18) To assess the contribution of cycling cardiomyocytes at the timepoints where the mRNA expression was the most profound (3 and 14 days”
BackgroundCardiomyocyte-fibroblast crosstalk in the postnatal heart
Calderon, M. U., Gonzalez, B. A., & Yutzey, K. E. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1163331 · Cited by 23
“As a response to cardiac injuries, such as cardiomyopathy or ischemia, resident fibroblasts become activated and further differentiate into additional dynamic states that mediate acute wound healing and long-term tissue remodeling with scarring (Moore-Morris et al., 2014a; Kanisicak et al., 2016; Fu et al., 2018).”
BackgroundEndothelial cell plasticity in kidney fibrosis and disease
Pohl, L., & Schießl, I. M. (2023) · Acta Physiologica · doi:10.1111/apha.14038 · Cited by 22
Exploring the Function of Epicardial Cells Beyond the Surface
Wong, D., Martinez, J., & Quijada, P. J. (2024) · Circulation Research · doi:10.1161/circresaha.124.321567 · Cited by 17
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.